Author： Bystricky Branislav Chau Ian
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.20, Iss.1, 2011-01, pp. : 107-117
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Treatment options in renal cancer
Inpharma, Vol. 1, Iss. 1394, 2003-01 ,pp. :
Treatment options for esophageal cancer
By Murphy Thomas J Ravi Narayamasamy Reynolds John V
Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 18, 2008-12 ,pp. :
Angiogenesis inhibitors in the treatment of cancer
Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 10, 2005-08 ,pp. :
Sorafenib for the treatment of renal cancer
Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 3, 2012-02 ,pp. :